Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,150

Quick answer

1,150 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8093246

    O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8093291

    Methods of using and compositions comprising tryptophan hydroxylase inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8093267

    Methods of treating rheumatoid arthritis

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8092812

    Methods and compositions for immunization against chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8092796

    Monoclonal antibodies against ANGPTL4

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8092809

    Pseudomonas exotoxin A-like chimeric immunogens

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8093354

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8092803

    VEGF antagonist formulations for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8093403

    Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8093214

    Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8092802

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8093236

    Weekly administration of dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8093343

    Nitric oxide-releasing diazeniumdiolated compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8093245

    4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8093274

    Inhibitors of protein prenyltransferases

    The Regents of the University of California · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8092830

    Lactic acid polymer and process for producing the same

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8093286

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8093280

    Methods of preparing imidazole-based compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8093382

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8092838

    Use of hydrogen sulfide in the treatment of eye diseases

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8093392

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8092988

    Medium and method of deriving and using a mutated bacteria strain

    United States of America as represented by the Secretary of the Air Force · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8097636

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8097695

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8097630

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8097612

    Compositions and methods relating to novel compounds and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8097701

    Aldehyde tags, uses thereof in site-specific protein modification

    The Regents of the University of California · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8097606

    Antiglucocorticoids for the treatment of catatonia

    Corcept Therapeutics Incorporated · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8097455

    System and method for forming skeletal muscle constructs having functional tissue interfaces

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8097610

    Derivative having PPAR agonistic activity

    Institute of Medicinal Molecular Design, Inc. · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8097713

    Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8097737

    Process for production of optically active amine derivatives

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8097759

    Inflammatory cytokine release inhibitor

    Institute of Medicinal Molecular Design, Inc. · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8101172

    Solenopsis invicta virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8101158

    Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity

    The Regents of the University of California · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8101742

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8101791

    Aminotetralin compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8101712

    Purification processes for echinocandin-type compounds

    TEVA Gyógyszergyár Zártkör{acute over ())}{acute over (})}úen M{acute over ())}{acute over (})}úköd{acute over ())}{acute over (})}ó Részvénytársaság · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8101641

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof

    PTC THERAPEUTICS, INC. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8101706

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Serina Therapeutics, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8101651

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8101647

    Spiro-oxindole compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8101630

    Extended release opioid abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8101579

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8101739

    Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8101740

    Positron emission tomography probes for imaging immune activation and selected cancers

    The Regents of the University of California · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8101584

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8101572

    Methods for promoting wound healing and/or reducing scar formation

    Arizona Board of Regents, A Corporate Body Organized Under Arizona Law · Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,150 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.